Panic disorder: Effective treatment options

American Family Physician

Volumn 57, Issue 10, 1998, Pages 2405-2412

  Atezaz Saeed, S ^a   Bruce, Timothy J ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CLOMIPRAMINE; CLONAZEPAM; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; IMIPRAMINE; INOSITOL; LORAZEPAM; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PETHIDINE; PHENELZINE; PLACEBO; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE; VERAPAMIL; ZIMELDINE;

AGORAPHOBIA; ANTICIPATION; AVOIDANCE BEHAVIOR; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; DISEASE ASSOCIATION; HUMAN; META ANALYSIS; PANIC; REVIEW; SIDE EFFECT;

HUMANS; PANIC DISORDER; PATIENT EDUCATION; PSYCHOTHERAPY; TEACHING MATERIALS;

EID: 2642619436     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, D.C.: American Psychiatric Association, 1994.
2. Katon W. Panic disorder: relationship to high medical utilization, unexplained physical symptoms, and medical costs. J Clin Psychiatry 1996;57(Suppl 10):11-8.
3. United States Department of Health and Human Services, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health. Panic disorder in the medical setting. Rockville, Md.: Government Printing Office, 1989; DHHS publication no. (ADM) 89-1629.
4. Ballenger JC. Panic disorder in the medical setting. J Clin Psychiatry 1997;58(Suppl 2):13-7.
5. Wolfe B, Maser JD. Treatment of panic disorder, a consensus development conference. Washington, D.C.: American Psychiatric Press, 1994.
6. Jefferson JW. Antidepressants in panic disorder. J Clin Psychiatry 1997;58(Suppl 2):20-4.
7. Kessel JB, Simpson GM. Tricyclic and tetracyclic drugs. In: Kaplan Hl, Sadock BJ, eds. Comprehensive textbook of psychiatry. 6th edition. Baltimore: Williams & Wilkins, 1995.
8. Black DW, Wesner R, Bowers W, Gabel J. A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder. Arch Gen Psychiatry 1993;50:44-50.
9. den Boer JA, Westenberg HG, Kamerbeek WD, Verhoeven WM, Kahn RS. Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine. Int Clin Psychopharmacol 1987;2:21-32.
10. Hoehn-Saric R, McLeod DR, Hipsley PA. Effect of fluvoxamine on panic disorder. J Clin Psychopharmacol 1993;13:321-6.
11. de Beurs E, van Balkom AJ, Lange A, Koele P, van Dyck R. Treatment of panic disorder with agoraphobia: comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone. Am J Psychiatry 1995;152:683-91.
12. Sheehan DV, Harnett-Sheehan K. The role of SSRIs in panic disorder. J Clin Psychiatry 1996;57(Suppl 10):51-8.
13. Lydiard RB, Ballenger JC. Panic-related disorders: evidence for efficacy of the antidepressants. Special issue: perspectives on panic-related disorders. J Anxiety Dis 1988;2:77-94.
14. Buigues J, Vallejo J. Therapeutic response to phenelzine in patients with panic disorder and agoraphobia with panic attacks. J Clin Psychiatry 1987;48:55-9.
15. Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. Cross-National Collaborative Panic Study, Second Phase Investigators. Br J Psychiatry 1992;160:191-202 [published erratum appears in Br J Psychiatry 1992;161:724].
16. Noyes R Jr, DuPont RL Jr, Pecknold JC, Rifkin A, Rubin RT, Swinson RP, et al. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety. Arch Gen Psychiatry 1988;45:423-8.
17. Davidson JR. Use of benzodiazepines in panic disorder. J Clin Psychiatry 1997;58(Supp) 2):26-8.
18. Owen RT, Tyrer P. Benzodiazepine dependence. A review of the evidence. Drugs 1983;25:385-98.
19. Spiegel DA, Bruce TJ, Gregg SF, Nuzzarello A. Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder? Am J Psychiatry 1994;151:876-81.
20. Ballenger JC, Lydiard RB, Turner SM. Panic disorder and agoraphobia. In: Gabbard GO, ed. Treatments of psychiatric disorders. Vol 2. Washington, D.C.: American Psychiatric Press, 1995.
21. DeMartinis NA, Schweizer E, Rickels K. An open-label trial of nefazodone in high comorbidity panic disorder. J Clin Psychiatry 1996;57:245-8.
22. Geracioti TD Jr. Venlafaxine treatment of panic disorder: a case series. J Clin Psychiatry 1995;56:408-10.
23. Benjamin J, Levine J, Fux M, Aviv A, Levy D, Belmaker RH. Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. Am J Psychiatry 1995;152:1084-6.
24. Charney DS, Woods SW, Goodman WK, Rifkin B, Kinch M, Aiken B, et al. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone. J Clin Psychiatry 1986;47:580-6.
25. Mavissakalian M, Perel J, Bowler K, Dealy R. Trazodone in the treatment of panic disorder and agoraphobia with panic attacks. Am J Psychiatry 1987;144:785-7.
26. Klein E, Uhde TW. Controlled study of verapamil for treatment of panic disorder. Am J Psychiatry 1988;145:431-4.
27. Keck PE Jr, Taylor VE, Tugrul KC, McElroy SL, Bennett JA. Valproate treatment of panic disorder and lactate-induced panic attacks. Biol Psychiatry 1993;33:542-6.
28. Boyer W. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis. Int Clin Psychopharmacol 1995;10:45-9.
29. Shear MK, Weiner K. Psychotherapy for panic disorder. J Clin Psychiatry 1997;58(Suppl 2):38-43.
30. Clark DM, Salkovskis PM, Hackmann A, Middleton H, Anastasiades P, Gelder M. A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. Br J Psychiatry 1994;164:759-69.
31. Barlow DH, Craske MG. Mastery of your anxiety and panic. II. Albany, N.Y.: Graywind, 1994.
32. Barlow DH. Cognitive-behavioral therapy for panic disorder: current status. J Clin Psychiatry 1997;58 (Suppl 2):32-6.
33. Gould RA, Otto MW, Pollack MH. A meta-analysis of treatment outcome for panic disorder. Clin Psych Rev 1995;15:819-44.
34. Brown TA, Barlow DH. Long-term outcome in cognitive-behavioral treatment of panic disorder: clinical predictors and alternative strategies for assessment. J Consult Clin Psychol 1995;63:754-65.
35. Rosenbaum JF, Pollock RA, Jordan SK, Pollack MH. The pharmacotherapy of panic disorder. Bull Menninger Clin 1996;60(Suppl A):A54-75.